Hsa_circ_0000190 has also been reported to accelerate the tumor progression and immune evasion of NSCLC through increasing soluble PD-L1 expression, and its high expression could serve as an effective indicator for anti-PD-L1 immunotherapy resistance and poor prognosis of NSCLC patients [291]. The gene discussed is CD274; the disease is neoplasm.